Delivery Order SPE2DB20D2104-SPE2DB22FT85L
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $3,943.90 for Myrbetriq ER 25 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $57,498.35 for the pharmaceutical product Myrbetriq ER 50 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and wholly-owned subsidiary of Cencora, Inc. The $28,159.98 firm-fixed-price delivery order is for Myrbetriq ER 50 mg tablets to be delivered by June 2, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,138.61 for the pharmaceutical product Myrbetriq ER 50 mg tablets. The contract was awarded on June 27, 2023, with a completion date of June 28, 2023, by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,758.57 fixed-price delivery order is for the supply of Myrbetriq ER 50 MG tablets to support various government healthcare programs and facilities. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,411.93 Firm Fixed Price Delivery Order contract is for the supply of Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award from the U.S. Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,660.02 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 MG tablets and has an ultimate completion date of October 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This federal contract award, valued at $33,308.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Myrbetriq ER 25 mg Tablets, with an ultimate completion date of October 31, 2022. This contract is not designated as a set-aside and is a firm-fixed price delivery order. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award, identified as SPE2DX15D1201|SPE2DX24F0Z2H, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,697.53 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,675.15 Firm Fixed Price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg tablet, with an ultimate completion date of October 24, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT85LDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,333.87 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which has no set-aside designation, is for the delivery of Myrbetriq ER 50 mg tablets to support the pharmaceutical and medical supply needs of federal healthcare programs, particularly military treatment facilities and veterans' healthcare. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with the DLA Troop Support Medical that serves as the primary vehicle for providing a comprehensive range of essential medications, medical devices, and other healthcare commodities to the Department of Defense and other federal agencies. The company also maintains a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's ability to efficiently meet the diverse pharmaceutical and medical supply requirements of multiple government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/7/22 |